NR1H4 and metabolic dysfunction-associated steatotic liver disease: It appears that PPE’s influence on NAFLD extends beyond hepatic factors as it impacts intestinal FXR-FGF15 signaling, offering a multifaceted approach to mitigate the development and progression of this complex metabolic disorder.